Breakthrough in Diabetes Research: Vascularized Stem Cell Islets offer a More Realistic Model for Studying and Treating the Disease
For decades, researchers have sought a reliable model to truly replicate the complex surroundings of the human pancreas, a critical step in understanding and ultimately curing diabetes. Now, a team led by Dr. Sander at the Max Delbrück Center has achieved a significant breakthrough: the creation of vascularized stem cell-derived islet (SC-islet) organoids that closely mimic the structure and function of native pancreatic islets. This advancement, published in Developmental cell, promises to revolutionize diabetes research and accelerate the growth of novel therapies.The Limitations of Current models & The Need for Vascularization
SC-islet organoids – miniature, lab-grown versions of pancreatic cell clusters responsible for insulin production – are already valuable tools for studying diabetes and related pancreatic diseases. However, a key limitation has been the immaturity of the beta cells within these organoids. While various strategies have been attempted to promote beta cell maturation, results have been incremental. The crucial missing element, researchers realized, was the intricate vascular network that naturally supports islet function in vivo - within a living organism.
“Our results underscore the fundamental importance of a functional vascular network in supporting pancreatic islet cell function,” explains Dr. Sander. “This model represents a significant leap forward in replicating the natural pancreatic environment, which is absolutely essential for both studying the intricacies of diabetes and developing effective new treatments.”
Engineering a Functional Vascular Network within Organoids
the team’s success hinged on a meticulous engineering process. They integrated human endothelial cells (which line blood vessels) and fibroblasts (cells that contribute to connective tissue) into SC-islet organoids derived from stem cells. The challenge wasn’t simply adding these cells, but creating an environment where they could survive, thrive, and build a functional vascular network.
After five years of dedicated experimentation, involving a collaborative team of stem cell biologists and bioengineers, they discovered a specific cell culture “recipe” – a carefully balanced cocktail of growth factors and conditions – that allowed the cells to not only survive but to self-assemble into a network of tube-like blood vessels that enveloped and penetrated the SC-islets. this represents a significant technical achievement in organoid engineering.
Demonstrating Enhanced Maturity and Function
the impact of vascularization was immediately apparent.When compared to non-vascularized organoids, the vascularized models demonstrated a considerably enhanced response to glucose. Specifically, they secreted more insulin when exposed to high glucose levels – a hallmark of mature, functional beta cells.
“Immature beta cells exhibit a diminished response to glucose,” Dr. Sander clarifies. “This finding unequivocally demonstrated that our vascularized model contained a higher proportion of mature, fully functional cells.”
Further examination revealed how vascularization drives maturation.Two key mechanisms were identified:
Extracellular Matrix formation: Endothelial cells and fibroblasts collaborate to build the extracellular matrix - a complex network of proteins and carbohydrates surrounding cells. The formation of this matrix itself acts as a crucial signal, prompting cells to mature.
BMP Secretion: Endothelial cells secrete Bone Morphogenetic Protein (BMP),a signaling molecule that directly stimulates beta cell maturation.
Mimicking physiological Conditions for Optimal Maturation
Recognizing that mechanical forces also play a role in insulin secretion, the researchers went a step further. They integrated the vascularized organoids into microfluidic devices, allowing for controlled nutrient delivery through the engineered vascular networks. This dynamic flow of nutrients further enhanced beta cell maturation, creating a gradient of maturity: non-vascularized < vascularized < vascularized with nutrient flow. "We observed a clear progression," Dr. Sander notes. "This gradient confirms that recreating the physiological environment - including vascular support and nutrient delivery - is critical for achieving optimal beta cell maturation." In-Vivo Validation: Improved Outcomes in Diabetic Mice
The team validated their findings in vivo by transplanting both vascularized and non-vascularized SC-islets into diabetic mice. The results were striking. Mice receiving non-vascularized SC-islets showed limited enhancement, while those receiving vascularized SC-islets experienced significant disease remission, with some exhibiting no signs of diabetes 19 weeks post-transplant. These findings align with previous research demonstrating the benefits of pre-vascularization for transplanted SC-islets.
Implications for Type 1 Diabetes Research and Beyond
This breakthrough has particularly exciting implications for research into Type 1 diabetes, an autoimmune disease where the body’s immune system attacks and destroys beta cells. Dr.Sander and her team are now leveraging the vascularized SC-islet organoid model to study the mechanisms of this immune-mediated destruction.
“We are growing vascularized organoids from cells obtained from patients